HULL, QC — June 17, 2002 —
Current treatments for amblyopia are beneficial and likely are curbing the rate of monocular visual loss, researchers report. Presented here Saturday at the annual meeting of the Canadian Ophthalmological Society (COS), a retrospective chart review looked at successes and complication rates associated with amblyopia therapies.
The condition, in which vision is impaired without any detectable organic lesion, affects 3.5 percent of children and is the most common cause of uniocular visual impairment in children and young adults. Previous research has indicated treatment in younger patients proves more successful than in older patients.
“Children develop amblyopia when they don’t have appropriate stimulation of their vision,” said Dr. Tanya Orton, principal investigator of the study and now a resident at the University of British Columbia. “They end up with decreased vision in one eye. It is usually treated with glasses or putting a patch on the healthy [eye], known as occlusion therapy, which gets the patient to use the affected eye. The goal of therapy is to increase vision.”
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!